NO894503L - Uretan-beskyttede aminosyre-n-karboksyanhydrider. - Google Patents

Uretan-beskyttede aminosyre-n-karboksyanhydrider.

Info

Publication number
NO894503L
NO894503L NO89894503A NO894503A NO894503L NO 894503 L NO894503 L NO 894503L NO 89894503 A NO89894503 A NO 89894503A NO 894503 A NO894503 A NO 894503A NO 894503 L NO894503 L NO 894503L
Authority
NO
Norway
Prior art keywords
amino acid
protected amino
carboxyan
uretane
hydrids
Prior art date
Application number
NO89894503A
Other languages
English (en)
Other versions
NO306304B1 (no
NO894503D0 (no
Inventor
William D Fuller
Robert K Blair
Michael Phillip Cohen
Murray Goodman
Original Assignee
Bioresearch Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Inc filed Critical Bioresearch Inc
Publication of NO894503L publication Critical patent/NO894503L/no
Publication of NO894503D0 publication Critical patent/NO894503D0/no
Publication of NO306304B1 publication Critical patent/NO306304B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyethers (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO894503A 1988-03-11 1989-11-10 Uretan-beskyttede aminosyre-N-karboksyanhydrider NO306304B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/168,087 US4946942A (en) 1988-03-11 1988-03-11 Urethane-protected amino acid-N-carboxyanhydrides
PCT/US1989/000875 WO1989008643A1 (en) 1988-03-11 1989-03-03 Urethane-protected amino acid-n-carboxyanhydrides

Publications (3)

Publication Number Publication Date
NO894503L true NO894503L (no) 1989-11-10
NO894503D0 NO894503D0 (no) 1989-11-10
NO306304B1 NO306304B1 (no) 1999-10-18

Family

ID=22610066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894503A NO306304B1 (no) 1988-03-11 1989-11-10 Uretan-beskyttede aminosyre-N-karboksyanhydrider

Country Status (21)

Country Link
US (1) US4946942A (no)
EP (1) EP0357750B1 (no)
JP (1) JP2875834B2 (no)
KR (1) KR970002229B1 (no)
CN (1) CN1022412C (no)
AT (1) ATE108438T1 (no)
AU (1) AU616054B2 (no)
CA (1) CA1321280C (no)
CZ (1) CZ148989A3 (no)
DD (1) DD280322A5 (no)
DE (1) DE68916722T2 (no)
FI (1) FI102379B1 (no)
HK (1) HK1007744A1 (no)
HU (1) HU205091B (no)
IE (1) IE65149B1 (no)
IL (1) IL89541A0 (no)
NO (1) NO306304B1 (no)
NZ (1) NZ228282A (no)
PT (1) PT89961B (no)
RU (1) RU2007396C1 (no)
WO (1) WO1989008643A1 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006661A (en) * 1987-06-16 1991-04-09 University Of Cincinnati Selective stereospecific biologically active beta-lactams
DE3839379A1 (de) * 1988-11-22 1990-05-23 Hoechst Ag Verfahren zur herstellung von tripeptiden
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US6379895B1 (en) 1989-06-07 2002-04-30 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6506558B1 (en) 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
DK0834575T3 (da) 1990-12-06 2002-04-02 Affymetrix Inc A Delaware Corp Identifikation af nucleinsyrer i prøver
US6468740B1 (en) 1992-11-05 2002-10-22 Affymetrix, Inc. Cyclic and substituted immobilized molecular synthesis
TW306932B (no) * 1993-08-27 1997-06-01 Holland Sweetener Co
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US7323298B1 (en) 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
IN184759B (no) * 1997-07-22 2000-09-23 Kaneka Corp
JP4405675B2 (ja) * 1998-07-21 2010-01-27 株式会社カネカ Ｎ−（１（ｓ）−エトキシカルボニル−３−フェニルプロピル）−ｌ−アラニル−ｌ−プロリンのマレイン酸塩の晶出方法
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
SE0000382D0 (sv) 2000-02-07 2000-02-07 Astrazeneca Ab New process
WO2002002538A1 (fr) * 2000-07-04 2002-01-10 Mitsui Chemicals, Inc. Anhydrides d'acide-amino-n-carboxy presentant un substituant a la position de l'azote
DE10333368B4 (de) * 2003-07-23 2008-08-28 Universität Leipzig Oberflächenfunktionalisiertes Trägermaterial, Verfahren zu dessen Herstellung und dessen Verwendungen
FR2858976B1 (fr) * 2003-08-22 2006-02-10 Isochem Sa Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane
US7294719B2 (en) * 2004-10-26 2007-11-13 Sigma-Aldrich Co. Synthesis of amino acid, N-carboxyanhydrides
CA2647325C (en) * 2005-12-12 2015-03-24 Allaccem, Inc. Methods and systems for preparing antimicrobial bridged polycyclic compounds
NZ579785A (en) 2007-02-21 2012-06-29 Allaccem Inc Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
WO2009017775A2 (en) * 2007-08-02 2009-02-05 Scinopharm Taiwan Ltd. Process for the preparation of a polypeptide
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
FR2928372B1 (fr) * 2008-03-10 2010-12-31 Solvay Procede de synthese peptidique
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
WO2012132991A1 (ja) * 2011-03-25 2012-10-04 日本曹達株式会社 グルタミン酸ベンジルエステルn－無水カルボン酸
US10526344B2 (en) 2015-03-17 2020-01-07 Regeneron Pharmaceuticals, Inc. Amino acid acylation reagents and methods of using the same
JP6766432B2 (ja) * 2016-04-28 2020-10-14 Jsr株式会社 ポリアミノ酸の製造方法
EP3590951A4 (en) * 2017-03-02 2021-01-06 Glytech, Inc. PROCESS FOR PRODUCING AN AMINO ACID POLYMER
CN112778236A (zh) * 2019-11-08 2021-05-11 华东理工大学 β、γ-氨基酸N-羧基硫代羰基环内酸酐单体的合成、聚合反应、聚合物制备及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173562A (en) * 1966-04-25 1969-12-10 Pierrel Spa Chloramphenicol Ester Salts, the Preparation therof and Compositions Containing them
US4267344A (en) * 1972-09-22 1981-05-12 Proteinkemisk Institut. Tilknyttet Akademiet For De Tekniske Videnskaber N-Substituted N-carboxyanhydrides of α-amino acids and their application in the preparation of peptides
US4038411A (en) * 1973-09-25 1977-07-26 Merck & Co., Inc. Antihypertensive amino acid esters
US4038282A (en) * 1975-11-26 1977-07-26 Merck & Co., Inc. Pyridyl-4-methyl-succinimidocarbonate and process for its preparation
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones

Also Published As

Publication number Publication date
AU616054B2 (en) 1991-10-17
US4946942A (en) 1990-08-07
IE65149B1 (en) 1995-10-04
HUT52488A (en) 1990-07-28
EP0357750A1 (en) 1990-03-14
ATE108438T1 (de) 1994-07-15
EP0357750B1 (en) 1994-07-13
HK1007744A1 (en) 1999-04-23
NO306304B1 (no) 1999-10-18
NZ228282A (en) 1990-10-26
AU4188789A (en) 1989-10-05
JP2875834B2 (ja) 1999-03-31
IL89541A0 (en) 1989-09-10
RU2007396C1 (ru) 1994-02-15
CN1022412C (zh) 1993-10-13
FI102379B (fi) 1998-11-30
CZ148989A3 (en) 1997-11-12
DD280322A5 (de) 1990-07-04
DE68916722D1 (de) 1994-08-18
NO894503D0 (no) 1989-11-10
CA1321280C (en) 1993-08-10
KR900700469A (ko) 1990-08-13
HU205091B (en) 1992-03-30
DE68916722T2 (de) 1994-11-03
FI895382A0 (fi) 1989-11-10
HU891841D0 (en) 1990-04-28
FI102379B1 (fi) 1998-11-30
PT89961A (pt) 1989-11-10
WO1989008643A1 (en) 1989-09-21
JPH02503923A (ja) 1990-11-15
IE890778L (en) 1989-09-11
EP0357750A4 (en) 1991-01-30
PT89961B (pt) 1994-04-29
KR970002229B1 (ko) 1997-02-26
CN1040793A (zh) 1990-03-28

Similar Documents

Publication Publication Date Title
NO894503L (no) Uretan-beskyttede aminosyre-n-karboksyanhydrider.
NL300106I1 (nl) N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE69324487D1 (de) Rezeptorbindende region des diphtherietoxius
DK0561907T3 (da) Proteiner med ændrede epitoper og fremgangsmåder til fremstilling deraf
DK0539530T3 (da) Rensningsstyret kloning af peptider
DE3856560D1 (de) Dem menschlichen gewebefaktor ähnliche dns-segmente, polypeptide und antikörper
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
ATE280227T1 (de) Epitope von stress proteinen
ATE110742T1 (de) Peptid-verbindungen.
DE3884316D1 (de) Synthetische Peptide, gegen diese gerichtete Antikörper und deren Verwendung.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
ES2032812T3 (es) Vacuna.
ATE92078T1 (de) Pharmakologisch aktive peptide.
NO982227D0 (no) Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav

Legal Events

Date Code Title Description
MK1K Patent expired